Journal article · 2026 · Open access

Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics

Bernadette Vallaster, Lisa Forster, Merlin Bresinsky, Lukas Wirth, Jessica L. Fuller, Ke Shi, Ian P. Lapcinski, Peng Liu, Deepti J. Mudaliar, Alexander Hubmann, Jonas Daschner, Herwig Pongratz and 5 more

Journal of Medicinal Chemistry · Published 5 November 2026 · DOI 10.1021/acs.jmedchem.6c01371

Open full textCite this paper

In brief

“Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics” is a 2026 journal article by Bernadette Vallaster and 16 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Medicinal Chemistry.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.39
References
57
Authors
17

Abstract

Caspase-2 (Casp2) has emerged as a promising target for tau-associated neurodegenerative diseases, yet the development of potent, selective, and drug-like inhibitors remains challenging. Here, we report a systematic structure–activity relationship study of 80 novel covalent-reversible peptidomimetic Casp2 inhibitors, revealing key structural features of the Casp2 S2–S3 binding site and discovering (S)-2-methylindoline-2-carboxylic acid (2-Me-Idc) and quinaldic acid (Quin) as versatile and stable P5 scaffolds. One-step conversion of the aldehyde warhead into a nitrile remarkably enhanced selectivity while maintaning potency. The results culminate in MUR-2425 (87, (2-Me-Idc)(hE)VP*D-CN), a nanomolar Casp2 inhibitor (pKi (cpCasp2) = 7.75) with ≥525-fold selectivity over Casp1/3/4/5/6/7/9/10 and 24-fold over Casp8. MUR-2425 prevents the formation of neurotoxic Δtau314 in vitro, exhibits stable ADMET properties across human, rat, and mouse species and proves brain penetrance after subcutaneous injection in CD-1 mice. MUR-2425 is confirmed to engage Casp2 covalently by cocrystallization, supporting its further development for Alzheimer’s disease and related dementias.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Vallaster, B., Forster, L., Bresinsky, M., Wirth, L., Fuller, J. L., Shi, K., Lapcinski, I. P., Liu, P., Mudaliar, D. J., Hubmann, A., Daschner, J., Pongratz, H., Ködel, M., Yang, M., Ashe, K. H., Walters, M. A., & Pockes, S. (2026). Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01371

MLA 9

Vallaster, Bernadette, et al. “Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c01371.

Chicago

Vallaster, Bernadette, Lisa Forster, Merlin Bresinsky, Lukas Wirth, Jessica L. Fuller, Ke Shi, Ian P. Lapcinski, et al. 2026. “Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01371.

Harvard

Vallaster, B. et al. (2026) ‘Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c01371.

IEEE

B. Vallaster et al., “Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c01371.

BibTeX

@article{vallaster2026refinement,
  title     = {{Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics}},
  author    = {Vallaster, Bernadette and Forster, Lisa and Bresinsky, Merlin and Wirth, Lukas and Fuller, Jessica L. and Shi, Ke and Lapcinski, Ian P. and Liu, Peng and Mudaliar, Deepti J. and Hubmann, Alexander and Daschner, Jonas and Pongratz, Herwig and Ködel, Marlisa and Yang, Mu and Ashe, Karen H. and Walters, Michael A. and Pockes, Steffen},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  doi       = {10.1021/acs.jmedchem.6c01371},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c01371}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • peptidomimetics
  • tauopathy
  • Alzheimer's disease
  • structure-activity relationship
  • covalent inhibitors
  • reversible inhibitors
  • quinaldic acid
  • nitrile conversion

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Vallaster, B., Forster, L., Bresinsky, M., Wirth, L., Fuller, J. L., Shi, K., Lapcinski, I. P., Liu, P., Mudaliar, D. J., Hubmann, A., Daschner, J., Pongratz, H., Ködel, M., Yang, M., Ashe, K. H., Walters, M. A., & Pockes, S. (2026). Refinement of Peptidomimetics toward MUR-2425: A Brain-Penetrant and Selective Caspase-2 Inhibitor with Enhanced Pharmacokinetics. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01371

How many times has this paper been cited?

1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Medicinal Chemistry: sign in and open the full text from this page.

Who wrote this paper?

Bernadette Vallaster, Lisa Forster, Merlin Bresinsky, Lukas Wirth, Jessica L. Fuller, Ke Shi, Ian P. Lapcinski, Peng Liu, Deepti J. Mudaliar, Alexander Hubmann, Jonas Daschner, Herwig Pongratz and 5 more.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c01371, permanently at https://doi.org/10.1021/acs.jmedchem.6c01371. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.